- Open Access
The yeast mitogen-activated protein kinase Slt2 is involved in the cellular response to genotoxic stress
© Soriano-Carot et al; licensee BioMed Central Ltd. 2012
- Received: 5 October 2011
- Accepted: 1 February 2012
- Published: 1 February 2012
The maintenance of genomic integrity is essential for cell viability. Complex signalling pathways (DNA integrity checkpoints) mediate the response to genotoxic stresses. Identifying new functions involved in the cellular response to DNA-damage is crucial. The Saccharomyces cerevisiae SLT2 gene encodes a member of the mitogen-activated protein kinase (MAPK) cascade whose main function is the maintenance of the cell wall integrity. However, different observations suggest that SLT2 may also have a role related to DNA metabolism.
This work consisted in a comprehensive study to connect the Slt2 protein to genome integrity maintenance in response to genotoxic stresses. The slt2 mutant strain was hypersensitive to a variety of genotoxic treatments, including incubation with hydroxyurea (HU), methylmetanosulfonate (MMS), phleomycin or UV irradiation. Furthermore, Slt2 was activated by all these treatments, which suggests that Slt2 plays a central role in the cellular response to genotoxic stresses. Activation of Slt2 was not dependent on the DNA integrity checkpoint. For MMS and UV, Slt2 activation required progression through the cell cycle. In contrast, HU also activated Slt2 in nocodazol-arrested cells, which suggests that Slt2 may respond to dNTP pools alterations. However, neither the protein level of the distinct ribonucleotide reductase subunits nor the dNTP pools were affected in a slt2 mutant strain. An analysis of the checkpoint function revealed that Slt2 was not required for either cell cycle arrest or the activation of the Rad53 checkpoint kinase in response to DNA damage. However, slt2 mutant cells showed an elongated bud and partially impaired Swe1 degradation after replicative stress, indicating that Slt2 could contribute, in parallel with Rad53, to bud morphogenesis control after genotoxic stresses.
Slt2 is activated by several genotoxic treatments and is required to properly cope with DNA damage. Slt2 function is important for bud morphogenesis and optimal Swe1 degradation under replicative stress. The MAPK Slt2 appears as a new player in the cellular response to genotoxic stresses.
- genotoxic stress
- DNA damage
- Saccharomyces cerevisiae
Genome stability and integrity maintenance are fundamental tasks in the cellular function. The DNA in each cell is under constant attack: genomic transactions, spontaneous chemical changes in DNA constituents, replication defects, and endogenous and exogenous agents, inflict damage to DNA. An efficient response to DNA damage is crucial to maintain cellular viability and to prevent diseases like cancer. Eukaryotic cells have developed surveillance mechanisms to respond to genotoxic stresses. These are the DNA damage and DNA replication checkpoints (referred to as DNA integrity checkpoints), a complex signaling network that coordinates cell cycle progression with DNA repair in response to DNA damage or defects in DNA replication to avoid genomic instability .
Checkpoint machinery is highly conserved in eukaryotes. The major regulators of the DNA-damage response are the PI3K-related protein kinases ATM (ataxia-telangiectasia mutated) and ATR (ATM and RAD3-related) kinases, Tel1 and Mec1, respectively in S. cerevisiae [2–5]. Tel1 and Mec1 have overlapping yet distinct functions in maintaining yeast genome integrity. Tel1 is specific in signaling double-strand breaks (DSBs). In contrast, Mec1 plays a more general role by functioning in the response to different types of damage, including DSBs, base adducts or crosslinks, and functions during the S phase to regulate the firing of replication origins. Early in the response, Mec1 and Tel1 are recruited to the sites of DNA damage together with accessory proteins that provide platforms on which damage response components are assembled. A final consequence is that Mec1 and Tel1 phosphorylate and activate the checkpoint effector kinases Chk1 and Rad53 . Rad53 mediates most of the response in budding yeast cells. Once phosphorylated, Rad53 is released from chromatin to act on critical targets that promote cell cycle arrest. Additionally, Rad53 targets factors to induce the expression of DNA repair genes, stimulates deoxyribonucleotide triphosphate (dNTP) production, suppresses the replication origins firing and stabilizes replication forks.
In most eukaryotic cells, cell cycle progression is blocked in response to DNA damage or replication stress mainly by stimulating inhibitory phosphorylation of cyclin-dependent kinases (Cdc28 in S. cerevisiae). This inhibition is controlled by the balance between the inhibitory Wee1 kinases (Swe1 in S. cerevisiae) and the opposite effect of the Cdc25 phosphatases (Mih1 in S. cerevisiae) . Budding yeast is an exception because this biochemical switch does not play a role in replication stress or DNA damage-induced cell cycle arrest. Instead, this control is the basis of the morphogenesis checkpoint, a mechanism that delays the mitotic activation of Cdc28 in response to many environmental stresses that provoke a transient depolarization of the actin cytoskeleton, which affects bud construction [8, 9]. However, more recent observations have also connected Swe1 regulation to some aspects of the response to interrupted DNA synthesis. Swe1 accumulates in hydroxyurea-treated cells in a DNA-damage checkpoint independent manner preventing Cdc28-associated mitotic activities. Later on Swe1 degradation is required for proper recovery from hydroxyurea-induced arrest . Swe1 degradation is triggered by the Mec1-Rad53 DNA-damage checkpoint cascade and plays also a crucial role in the control of morphogenetic events during DNA replication stress . In particular, the DNA-damage checkpoint triggers the switch from apical to isotropic bud growth to maintain proper bud morphogenesis. Actin cytoskeleton dynamics along the cell cycle is controlled by different cyclin-Cdc28 kinases [12, 13]. The switch from apical to isotropic bud growth requires activation of the mitotic Clb1,2-Cdc28 kinases in the G2 phase. During the response to DNA damage, Mec1-Rad53 activation causes Swe1 degradation, which allows to build up Clb1,2-Cdc28 activity to switch off apical bud growth.
Mitogen-activated protein kinases (MAPK) are at the core of many signal transduction pathways, orchestrating specific cellular responses to a wide range of stimuli . S.cerevisiae cells contain five MAPK that regulate mating (Fus3), pseudohyphal/invasive growth (Kss1), sporulation (Smk1), response to high osmolarity (Hog1) and response to cell wall stress (Slt2) . Slt2 is the MAPK of the cell wall integrity pathway [16, 17]. Slt2 is a functional homolog of human ERK5 , a MAPK that is activated in response to not only growth factors, but also physical and chemical stresses [19, 20]. In yeast, Slt2 is activated under conditions that stress the cell surface, such as growth at high temperatures, hypo-osmotic shock, polarized growth, actin perturbation, or the presence of compounds or mutations that interfere with cell wall biosynthesis . Once activated, Slt2 controls the expression of the genes involved in cell wall biosynthesis through the regulation of transcription factors Rlm1 and SBF (Swi4-Swi6) to maintain cell integrity [22–24]. In addition to gene expression control, Slt2 is also related to the regulation of actin cytoskeleton polarization  and contributes, although partially, to the mitotic delay induced by Ca2+ or actin cytoskeleton perturbation as part of the morphogenesis checkpoint mechanism [26, 27]. Slt2 is also involved in the cellular response to oxidative stress through the control of cyclin C degradation . Cross-talks between MAPK pathways are common. Thus, the Hog1 kinase (the functional homolog of mammalian p38 MAPK) has been recently described to operate with Slt2 in the adaptation to zymolyase-mediated cell wall stress .
MAPKs have been related to the response to DNA damage. Mammalian MAPKs are grouped into the ERK, JNK/SAPK and p38 families [30, 31]. Different genotoxic treatments activate p38, which contributes to the establishment of cell cycle checkpoints . Activation of p38 involves the ATM/ATR checkpoint pathway, along with other mechanisms which are yet to be established. Activation of ERK and JNK kinases is also induced by multiple DNA damage stimuli [33–38]. Moreover, both ERK1 and ERK2 kinases are required for the proper checkpoint activation by facilitating activation of ATM and ATR [39–42]. Regarding S. cerevisiae, we previously showed that Slt2 is activated by hydroxyurea and that the slt2 mutant is sensitive to this drug . Furthermore, genetic interactions have connected Slt2 to DNA-damage checkpoint proteins and the response to MMS [43, 44]. Here, we extend our work by carrying out a comprehensive analysis of the connection of Slt2 MAPK with the cellular response to different types of DNA damage caused by a wide range of genotoxic agents.
The slt2 mutant strain is hypersensitive to genotoxic agents
Slt2 is activated by genotoxic stresses
Analysis of Slt2 activation in DNA-damage checkpoint mutants
The cellular response to genotoxic stress is governed by the DNA integrity checkpoint pathway. We wondered whether Slt2 activation by genotoxic stresses was mediated by the DNA damage checkpoint. To investigate this, activation of Slt2 by HU or MMS was analyzed in the mutant strains in checkpoint upstream kinases Mec1 and Tel1 or in the effector kinase Rad53 (Figure 4). Rad53 and Mec1 are essential genes so we used in these cases strains containing the sml1 mutation, which is known to suppress rad53 and mec1 lethality. It is noteworthy that strong Slt2 activation took place in the absence of genotoxic agents in rad53 and mec1 tel1 mutant strains. This is in agreement with previously reported results and is probably a response to the cell morphology and cell wall defects characteristic of these checkpoint kinase mutants . Another important aspect is that incubation with HU or MMS brought about higher levels of activated Slt2 in the tel1, mec1, mec1 tel1 or rad53 mutant cells. A similar result was obtained with the tetO 7 :RAD53 mutant strain. These results demonstrate that Slt2 activation by genotoxic stress is not mediated by the DNA damage checkpoint.
Slt2 is activated by HU in post-replicative cells
As the response to genotoxic stress varies depending on the cell cycle stage [45–48], we wondered whether Slt2 activation in response to genotoxic agents depends on the cell cycle stage. Accordingly, Slt2 activation by HU, MMS and UV radiation was analyzed in cells arrested in G1 with α-factor and cells arrested in G2/M by inactivating the CDC20 gene (Figure 5A). A mild Slt2 activation was observed in G1 cells treated with HU. By contrast, no significant increase in phosphorylated Slt2 due to incubation of cells with MMS or UV irradiation was detected in G1 cells; however, it has to be noted that α-factor caused Slt2 activation, which could preclude genotoxic-induced Slt2 activation. In G2/M cells, no activation was observed in the presence of MMS or after UV irradiation in contrast to what was detected in cycling cells. These results suggest that Slt2 activation by MMS or UV radiation probably occurs during the S phase. On the contrary, Slt2 was activated by HU in G2/M cells. We wondered whether Slt2 activation by HU could be related to mitochondrial DNA replication; however, the fact that Slt2 activation is also observed in a rho 0 derived strain ruled out this possibility (Figure 5B). HU is an inhibitor of ribonucleotide reductase, which catalyzes the limiting step in dNTP biosynthesis. Incubation of cells with HU causes a reduction of dNTP pools and a consequent blockage of S phase progression. The fact that HU affects Slt2 activity in post-replicative cells suggests that Slt2 activation could be, at least in part, a direct response to an alteration of the nucleotide pools, which also could indicate that Slt2 might be involved in the control of dNTP pools.
Analysis of dNTP pools in the absence of Slt2
Analysis of DNA-integrity checkpoint activation in the slt2 mutant strain
We also analyzed cell cycle arrest after inducing DNA damage with MMS. In this case, there was no homogenous terminal morphology, but cell cycle arrest was revealed by the DNA content analysis, showing a clear accumulation of cells with non-replicated DNA after a 1-hour incubation in the presence of MMS. Importantly, this accumulation was observed in both the wild-type and the slt2 mutant strains (Figure 7B). Thus, MMS-induced cell cycle arrest occurs in the absence of Slt2.
Finally, we also investigated whether checkpoint activation normally occurs in the absence of Slt2. To test this, slt2 mutant cells were subjected to replicative stress or DNA damage by incubation with HU or MMS, respectively, and the presence of phosphorylated Rad53, as indicative of checkpoint activation, was analysed by Western blot. The results showed that phosphorylated Rad53 accumulated at similar levels in the wild-type and slt2 mutant strains after genotoxic treatments (Figure 7C). Thus, the DNA damage checkpoint is functional in the absence of Slt2, at least until the Rad53 activation step.
Slt2 has a pseudo-kinase paralog in yeast, protein Mlp1. Mlp1 shares a function with Slt2 in transcriptional activation . Therefore, it is possible that Mlp1 could be functionally redundant with Slt2, and that it could activate the DNA integrity checkpoint in the absence of Slt2. However, we detected a proper activation of Rad53 by HU and MMS in the mlp1 and slt2 mlp1 mutant strains (Figure 7C). This observation confirms that Slt2 kinase and its relative Mlp1 protein are not required for proper Rad53 activation.
Increasing evidence indicates there are cross-talks between the MAPK cascades in yeast. Hog1, the MAPK involved in the response to osmotic stress, is especially interesting because recent works have related the Slt2 and Hog1 functions in the activation of the cell wall gene expression . Furthermore, Hog1 is the yeast homolog to mammalian p38 MAPK. As mentioned above, p38 plays an important role in cell cycle checkpoints in response to DNA damage. Therefore, we investigated whether Hog1 was involved in Rad53 activation. However, this was not the case because phosphorylated Rad53 normally accumulated after HU and MMS treatments in the absence of Hog1 (Figure 7C). Moreover, no defect in Rad53 activation was detected in a slt2 hog1 double mutant, which ruled out any functional redundancy between Slt2 and Hog1 in checkpoint activation.
Slt2 is required for the proper degradation of Swe1 after DNA damage
Activation of cell-cycle checkpoints in response to various types of DNA damage is essential for the maintenance of genomic stability in eukaryotic cells. This work describes how the Slt2 MAP kinase is activated in response to DNA damage and that Slt2 is essential to properly cope with genotoxic stresses. Slt2 is involved in cell wall assembly and is activated by cell wall damage, so it could be possible that slt2 mutant hypersensitivity to genotoxic treatments or Slt2 activation simply result from increased cell wall permeability or unknown cell wall damage caused by the treatments. This possibility is unlikely, however, because hypersensitivity to genotoxic treatments is also observed in the presence of sorbitol, which indicates that cell death is not related to cell wall defects. Most remarkably, Slt2 activation after induction of a single DSB in the GAL1:HO strain, a process that has a specific effect on DNA integrity and is not related to cell wall, strongly supports a genuine role for Slt2 in the response to genotoxic stress. This conclusion is also reinforced by a recent genetic interaction network analysis that connected Slt2 to the cellular response to MMS . It is important to note that both Slt2 activation and hypersensitivity of the slt2 mutant are observed in response to a wide range of genotoxic stresses, which result in different types of DNA damage: e.g., DSB, thymidine dimers, nucleotide alkylation or replicative forks stalling. This reinforces the importance of Slt2 in the response to genotoxic stresses and suggests that Slt2 could play a common role in the response to different types of damage.
Response to DNA damage is primarily governed by the activation of the DNA-integrity checkpoints. However, Slt2 is activated even in the absence of a functional checkpoint, indicating that genotoxic stress is transduced to the Slt2 kinase by a checkpoint-independent mechanism. In fact, Slt2 activation and Rad53 activation after inducing DNA damage occur independently of each other. Thus, both kinases appear to fulfill complementary functions necessary for cell survival in parallel independent DNA-damage signaling pathways. This indicates that the response of yeast cells to genotoxic stresses could be more complex than previously suspected, and may involve new crucial players like Slt2 MAPK. In mammalian cells, p38 MAPK activation in response to DNA damage has been reported to be dependent on ATM/ATR checkpoint kinases in some cases; however, in addition to the checkpoint pathway, other mechanisms still to be established activate p38 MAPK in response to DNA damage . Thus, a mechanism directly linking MAPK activation to DNA damage could be conserved in eukaryotic cells.
It is not clear how genotoxic stresses could activate Slt2. We have observed that upregulation of Slt2 is mostly, if not totally, mediated by a post-translational mechanism. As commented above, Slt2 activation occurs in osmotically supported cells or in cdc42 mutant cells that cannot bud  and it was observed after specific induction of a single DSB, which strongly suggests that Slt2 activation is not an indirect effect. The observed Slt2 activation could be a direct result of DNA lesions. Remarkably, however, Slt2 activation by MMS and UV is cell cycle-regulated since it does not occur in the cells arrested in G2/M. This suggests that Slt2 does not respond to primary damage and should be related to alterations that appear as damaged cells progress through the cell cycle.
Activation by HU seems to be a different case since HU induced Slt2 activation, even in G2/M-arrested cells. It could be expected that HU stress would only affect cells that were actively replicating DNA. The fact that HU induced activation is also observed in post-replicative cells, i.e., cells that do not consume dNTP pools, suggests that Slt2 could respond directly to the inhibition of ribonucleotide reductase activity and the reduction in dNTP pool levels. Very recently, Slt2 has been suggested to repress the expression of the RNR1,2,3 genes, as deduced from the increase in mRNAs observed in the slt2 mutant strain . However, we detected no change in the protein level in any ribonucleotide reductase subunit after Slt2 inactivation in both untreated and MMS-treated cells. More importantly, dNTP pools, which reflect the physiological function of ribonucleotide reductase activity, were not altered in the slt2 mutant under any analyzed condition. Thus, our results argue against a role of Slt2 in controlling ribonucleotide reductase and dNTP pools.
Our findings show that Slt2 plays an important part in the general cellular response to genotoxic stress. Slt2 could mediate a defensive mechanism developed by yeast cells to overcome treatments affecting DNA integrity. Primary cellular defense to DNA damage involves cell cycle arrest to facilitate DNA repair prior to progression through the S phase or mitosis. It is known that Slt2 contributes to the delay of the G2/M transition in response to actin stress [26, 27]. However, this is not the case in the response to genotoxic stress since cell cycle arrest occurs in the absence of Slt2. Alternatively, it is tempting to speculate that Slt2 could directly favour DNA damage repair. On the other hand, involvement of Slt2 in the response to genotoxic stress could be related with its known function in cell morphogenesis, the actin cytoskeleton and cell integrity. Although this idea may seem surprising, there is increasing evidence for a direct cross-talk between the DNA checkpoint pathway and cellular morphogenesis. Thus, various checkpoint proteins contribute to cell wall architecture and maintenance of cell polarity , Cdk1 regulates Rad53 to orchestrate cellular morphogenesis during cell cycle , Rad53 interacts with septins in the bud neck and directs filamentous differentiation in response to genotoxic stress , Rad53 phosphorylates Slt2 to control the Slt2-dependent expression of the cell wall FKS2 gene in response to caffeine , the Mdt1 protein has partially separable functions in both the cell wall and genome integrity pathways , and we have observed a synthetic lethality between slt2 and rad53 mutations that is suppressed by sorbitol, which suggests that lethality is caused by a morphogenetic defect. In fact, bud morphogenesis control has been described as an output of DNA replication checkpoint activation , which clearly demonstrates the link between genome maintenance and cell morphogenesis. We have observed that Slt2 is related to the morphogenetic aspects of the replicative stress response. In budding yeast cells, actin cytoskeleton polarization has to be regulated during DNA damage-induced cell cycle arrest to maintain bud morphogenesis. Thus during the response to DNA damage, checkpoint activation has been described to cause degradation of the Swe1 kinase , which is the main protein involved in the morphogenesis checkpoint controlling bud growth [8, 9]. This leads to the activation of the Clb1,2-Cdc28 kinases, which are responsible for the switch from apical to isotropic bud growth, an essential switch for proper bud morphogenesis [12, 13]. We have observed that Swe1 degradation after replicative stress is partially impaired in the absence of Slt2, causing altered bud morphogenesis in slt2 cells. Defects in Swe1 degradation has been related to HU sensitivity , which could explain slt2 phenotype. However, HU and other genotoxic treatments caused a reduced viability of slt2 mutant cells even in the absence of Swe1, which indicates that Slt2 must affect cell viability by a Swe1-independent mechanism. How Slt2 influences Swe1 stability is intriguing, and even more so if we consider that this effect is apparently contradictory to the results previously described in the morphogenesis checkpoint context  or in response to Ca2+ . In these cases, Slt2 acts by activating Swe1 or by repressing Mih1 to inhibit Cdc28 kinase activity, whereas in the response to replicative stress, Slt2 seems to act by inactivating Swe1 to induce Cdc28 kinase activity. Elucidating the molecular basis of the Slt2 function in the response to genotoxic stresses will help explain this apparent contradiction and to gain insight into the molecular link between cellular morphogenesis and integrity with genome integrity maintenance.
Our results support a function of MAPK Slt2 in the maintenance of DNA integrity. Inactivation of Slt2 results in hypersensitivity to many types of genotoxic treatments. Moreover, Slt2 is activated by several genotoxic stresses. These results suggest that Slt2 play an important role in the cellular response to DNA damage. Slt2 activation by MMS and UV, but not HU, requires cell cycle progression. Slt2 is not involved in dNTP pools regulation and is not required for DNA-damage induced cell cycle arrest or checkpoint activation. Nevertheless, Slt2 function is important for bud morphogenesis control and optimal Swe1 degradation under replicative stress. The results described here point to the MAPK Slt2 as a new player in the cellular response to genotoxic stresses.
Strains and growth conditions
MATa ade2-1 trp1-1 leu2-3,112 his3-11,15 ura3-52 can1 rad5-535
MATa ade2-101 trp1-Δ902 leu2-3,112 his3-Δ200 ura3-52 RAD5
MATa ade1-100 trp1-1 leu2-3,112 lys5 ura3-52 trp1::hisG hoΔ hml::ADE1 hmr::ADE1 ade3::GAL-HO RAD5
slt2::LEU2 in SEY6211
rad53::HIS3 sml1-1 in W303-1a
mec1::TRP1 sml1::HIS3 in W303-1a
slt2::TRP1 in W303-1a
sml1::kanMX6 in W303-1a
tTR'::LEU2 tetO 7 ::RAD53-kanMX4 in W303-1a
tel1:: kanMX6 in W303-1a
tel1:: kanMX6 in JCY1039
SWE1-HA-kanMX6 in W303-1a
SWE1-HA-kanMX6 in JCY1062
mlp1::kanMX6 in W303-1a
mlp1::kanMX6 in JCY1062
hog1::kanMX4 in W303-1a
hog1::kanMX4 in JCY1062
swe1::kanMX6 in W303-1a
swe1::kanMX6 in JCY1062
GAL1:CDC20-TRP1 in W303-1a
Western blot analysis
Approximately 108 cells were collected, resuspended in 100 μl water and, after adding 100 μl 0.2 M NaOH, they were incubated for 5 min at room temperature. Cells were collected by centrifugation, resuspended in 50 μl sample buffer and incubated for 5 min at 95°C. Extracts were clarified by centrifugation, and equivalent amounts of protein were resolved in an SDS-PAGE gel and transferred onto a nitrocellulose membrane. The primary antibodies used in this study include anti-fosfo-44/42 Map kinasa Thr200/Tyr204 (Cell Signalling) to detect activated Slt2, anti Mpk1-yC20 (Santa Cruz Biotechnology) to detect total Slt2 protein, anti Rad53-YC19 (Santa Cruz Biotechnology), anti-HA 3F10 monoclonal antibody (Roche), and anti Rnr1, Rnr2, Rnr3 and Rnr4 (kindly provided by M. Huang, University of Colorado). Blots were developed with HRP-labeled secondary antibodies using the ECL Advance Western Blotting Detection Kit (GE Healthcare Life Sciences). Bands were quantified with a ImageQuant™ LAS 4000mini biomolecular imager (GE Healthcare).
dATP, dCTP and dGTP measurements
Approximately 2 × 108 cells were harvested, washed with water, resuspended in 200 μL of cold 60% methanol, and extracts obtained by vigorous shacking in the presence of glass beads. Then, cell debris was pelleted at 27000 g for 1 min, and the supernatant was held at -20°C for 2 h. The samples were boiled for 3 min, and followed by centrifugation at 13000 g for 10 min at 4°C. The supernatant was taken to dryness under vacuum and resuspended in 40 μL of water. The dATP, dCTP and dGTP levels were determined by the DNA polymerase-based enzymatic assay . Briefly, the incorporation by the Klenow DNA polymerase of dATP, dCTP and dGTP into specific oligonucleotides containing poly(AAAT), poly(AAAG) or poly(AAAC) sequences respectively, was determined in the presence of excess [3H]dTTP.
We are very grateful to Dr. I. Quilis for her collaboration. Dr. J. Torres, Dr. J.E. Haber Dr. E. Herrero and Dr. J.R. Pringle for supplying strains and plasmids. We also thanks Dr. M. Huang for kindly provide anti-Rnr antibodies. This work was supported by Grants BFU2007-67929-C02-02 and BFU2010-20927 from Ministerio de Ciencia e Innovación of the Spanish Government (co-financed by ERDF from European Union) and ACOMP/2010/134 from Generalitat Valenciana. M.S. was recipient of a F.P.I: Predoctoral Fellowship from the Spanish Governement.
- Harper JW, Elledge SJ: The DNA damage response: ten years after. Mol Cell 2007,28(5):739–745.View ArticlePubMedGoogle Scholar
- Cimprich KA, Cortez D: ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 2008,9(8):616–627.View ArticlePubMed CentralPubMedGoogle Scholar
- Harrison JC, Haber JE: Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 2006, 40: 209–235.View ArticlePubMedGoogle Scholar
- Navadgi-Patil VM, Burgers PM: The unstructured C-terminal tail of the 9–1-1 clamp subunit Ddc1 activates Mec1/ATR via two distinct mechanisms. Mol Cell 2009,36(5):743–753.View ArticlePubMed CentralPubMedGoogle Scholar
- Shiloh Y: The ATM-mediated DNA-damage response: taking shape. Trends Biochem Sci 2006,31(7):402–410.View ArticlePubMedGoogle Scholar
- Melo J, Toczyski D: A unified view of the DNA-damage checkpoint. Curr Opin Cell Biol 2002,14(2):237–245.View ArticlePubMedGoogle Scholar
- Raleigh JM, O'Connell MJ: The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. J Cell Sci 2000,113(Pt 10):1727–1736.PubMedGoogle Scholar
- Lew DJ: The morphogenesis checkpoint: how yeast cells watch their figures. Curr Opin Cell Biol 2003,15(6):648–653.View ArticlePubMedGoogle Scholar
- Kellogg DR: Wee1-dependent mechanisms required for coordination of cell growth and cell division. J Cell Sci 2003,116(Pt 24):4883–4890.View ArticlePubMedGoogle Scholar
- Liu H, Wang Y: The function and regulation of budding yeast Swe1 in response to interrupted DNA synthesis. Mol Biol Cell 2006,17(6):2746–2756.View ArticlePubMed CentralPubMedGoogle Scholar
- Enserink JM, Smolka MB, Zhou H, Kolodner RD: Checkpoint proteins control morphogenetic events during DNA replication stress in Saccharomyces cerevisiae. J Cell Biol 2006,175(5):729–741.View ArticlePubMed CentralPubMedGoogle Scholar
- Pruyne D, Bretscher A: Polarization of cell growth in yeast. J Cell Sci 2000,113(Pt 4):571–585.PubMedGoogle Scholar
- Pruyne D, Bretscher A: Polarization of cell growth in yeast. I. Establishment and maintenance of polarity states. J Cell Sci 2000,113(Pt 3):365–375.PubMedGoogle Scholar
- Qi M, Elion EA: MAP kinase pathways. J Cell Sci 2005,118(Pt 16):3569–3572.View ArticlePubMedGoogle Scholar
- Chen RE, Thorner J: Function and regulation in MAPK signaling pathways: lessons learned from the yeast Saccharomyces cerevisiae. Biochim Biophys Acta 2007,1773(8):1311–1340.View ArticlePubMed CentralPubMedGoogle Scholar
- Lesage G, Bussey H: Cell wall assembly in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2006,70(2):317–343.View ArticlePubMed CentralPubMedGoogle Scholar
- Levin DE: Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 2005,69(2):262–291.View ArticlePubMed CentralPubMedGoogle Scholar
- Truman AW, Millson SH, Nuttall JM, King V, Mollapour M, Prodromou C, Pearl LH, Piper PW: Expressed in the yeast Saccharomyces cerevisiae, human ERK5 is a client of the Hsp90 chaperone that complements loss of the Slt2p (Mpk1p) cell integrity stress-activated protein kinase. Eukaryot Cell 2006,5(11):1914–1924.View ArticlePubMed CentralPubMedGoogle Scholar
- Abe J, Kusuhara M, Ulevitch RJ, Berk BC, Lee JD: Big mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J Biol Chem 1996,271(28):16586–16590.View ArticlePubMedGoogle Scholar
- Yan C, Luo H, Lee JD, Abe J, Berk BC: Molecular cloning of mouse ERK5/BMK1 splice variants and characterization of ERK5 functional domains. J Biol Chem 2001,276(14):10870–10878.View ArticlePubMedGoogle Scholar
- Harrison JC, Zyla TR, Bardes ES, Lew DJ: Stress-specific activation mechanisms for the "cell integrity" MAPK pathway. J Biol Chem 2004,279(4):2616–2622.View ArticlePubMedGoogle Scholar
- Baetz K, Moffat J, Haynes J, Chang M, Andrews B: Transcriptional coregulation by the cell integrity mitogen-activated protein kinase Slt2 and the cell cycle regulator Swi4. Mol Cell Biol 2001,21(19):6515–6528.View ArticlePubMed CentralPubMedGoogle Scholar
- Kim KY, Truman AW, Levin DE: Yeast Mpk1 mitogen-activated protein kinase activates transcription through Swi4/Swi6 by a noncatalytic mechanism that requires upstream signal. Mol Cell Biol 2008,28(8):2579–2589.View ArticlePubMed CentralPubMedGoogle Scholar
- Watanabe Y, Takaesu G, Hagiwara M, Irie K, Matsumoto K: Characterization of a serum response factor-like protein in Saccharomyces cerevisiae, Rlm1, which has transcriptional activity regulated by the Mpk1 (Slt2) mitogen-activated protein kinase pathway. Mol Cell Biol 1997,17(5):2615–2623.PubMed CentralView ArticlePubMedGoogle Scholar
- Guo S, Shen X, Yan G, Ma D, Bai X, Li S, Jiang Y: A MAP kinase dependent feedback mechanism controls Rho1 GTPase and actin distribution in yeast. PLoS One 2009,4(6):e6089.View ArticlePubMed CentralPubMedGoogle Scholar
- Harrison JC, Bardes ES, Ohya Y, Lew DJ: A role for the Pkc1p/Mpk1p kinase cascade in the morphogenesis checkpoint. Nat Cell Biol 2001,3(4):417–420.View ArticlePubMedGoogle Scholar
- Mizunuma M, Hirata D, Miyahara K, Tsuchiya E, Miyakawa T: Role of calcineurin and Mpk1 in regulating the onset of mitosis in budding yeast. Nature 1998,392(6673):303–306.View ArticlePubMedGoogle Scholar
- Krasley E, Cooper KF, Mallory MJ, Dunbrack R, Strich R: Regulation of the oxidative stress response through Slt2p-dependent destruction of cyclin C in Saccharomyces cerevisiae. Genetics 2006,172(3):1477–1486.View ArticlePubMed CentralPubMedGoogle Scholar
- Garcia R, Rodriguez-Pena JM, Bermejo C, Nombela C, Arroyo J: The high osmotic response and cell wall integrity pathways cooperate to regulate transcriptional responses to zymolyase-induced cell wall stress in Saccharomyces cerevisiae. J Biol Chem 2009,284(16):10901–10911.View ArticlePubMed CentralPubMedGoogle Scholar
- Raman M, Chen W, Cobb MH: Differential regulation and properties of MAPKs. Oncogene 2007,26(22):3100–3112.View ArticlePubMedGoogle Scholar
- Cargnello M, Roux PP: Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75(1):50–83.Google Scholar
- Thornton TM, Rincon M: Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci 2009,5(1):44–51.View ArticlePubMed CentralPubMedGoogle Scholar
- Persons DL, Yazlovitskaya EM, Pelling JC: Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin. J Biol Chem 2000,275(46):35778–35785.View ArticlePubMedGoogle Scholar
- Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP, Aaronson SA: Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc Natl Acad Sci USA 2000,97(15):8302–8305.View ArticlePubMed CentralPubMedGoogle Scholar
- Wang X, Martindale JL, Holbrook NJ: Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 2000,275(50):39435–39443.View ArticlePubMedGoogle Scholar
- Tang D, Wu D, Hirao A, Lahti JM, Liu L, Mazza B, Kidd VJ, Mak TW, Ingram AJ: ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem 2002,277(15):12710–12717.View ArticlePubMedGoogle Scholar
- Pippin JW, Durvasula R, Petermann A, Hiromura K, Couser WG, Shankland SJ: DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes. J Clin Invest 2003,111(6):877–885.View ArticlePubMed CentralPubMedGoogle Scholar
- Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S: MAPK pathways in radiation responses. Oncogene 2003,22(37):5885–5896.View ArticlePubMedGoogle Scholar
- Wei F, Xie Y, He L, Tao L, Tang D: ERK1 and ERK2 kinases activate hydroxyurea-induced S-phase checkpoint in MCF7 cells by mediating ATR activation. Cell Signal 2011,23(1):259–268.View ArticlePubMedGoogle Scholar
- Wei F, Xie Y, Tao L, Tang D: Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation. Cell Signal 2010,22(11):1783–1789.View ArticlePubMedGoogle Scholar
- Yan Y, Black CP, Cowan KH: Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene 2007,26(32):4689–4698.View ArticlePubMedGoogle Scholar
- Mogila V, Xia F, Li WX: An intrinsic cell cycle checkpoint pathway mediated by MEK and ERK in Drosophila. Dev Cell 2006,11(4):575–582.View ArticlePubMed CentralPubMedGoogle Scholar
- Queralt E, Igual JC: Functional connection between the Clb5 cyclin, the protein kinase C pathway and the Swi4 transcription factor in Saccharomyces cerevisiae. Genetics 2005,171(4):1485–1498.View ArticlePubMed CentralPubMedGoogle Scholar
- Bandyopadhyay S, Mehta M, Kuo D, Sung MK, Chuang R, Jaehnig EJ, Bodenmiller B, Licon K, Copeland W, Shales M, et al.: Rewiring of genetic networks in response to DNA damage. Science 2010,330(6009):1385–1389.View ArticlePubMed CentralPubMedGoogle Scholar
- Pellicioli A, Lee SE, Lucca C, Foiani M, Haber JE: Regulation of Saccharomyces Rad53 checkpoint kinase during adaptation from DNA damage-induced G2/M arrest. Mol Cell 2001,7(2):293–300.View ArticlePubMedGoogle Scholar
- Ira G, Pellicioli A, Balijja A, Wang X, Fiorani S, Carotenuto W, Liberi G, Bressan D, Wan L, Hollingsworth NM, et al.: DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1. Nature 2004,431(7011):1011–1017.View ArticlePubMed CentralPubMedGoogle Scholar
- Leroy C, Mann C, Marsolier MC: Silent repair accounts for cell cycle specificity in the signaling of oxidative DNA lesions. EMBO J 2001,20(11):2896–2906.View ArticlePubMed CentralPubMedGoogle Scholar
- Tercero JA, Longhese MP, Diffley JF: A central role for DNA replication forks in checkpoint activation and response. Mol Cell 2003,11(5):1323–1336.View ArticlePubMedGoogle Scholar
- Diani L, Colombelli C, Nachimuthu BT, Donnianni R, Plevani P, Muzi-Falconi M, Pellicioli A: Saccharomyces CDK1 phosphorylates Rad53 kinase in metaphase, influencing cellular morphogenesis. J Biol Chem 2009,284(47):32627–32634.View ArticlePubMed CentralPubMedGoogle Scholar
- Smolka MB, Chen SH, Maddox PS, Enserink JM, Albuquerque CP, Wei XX, Desai A, Kolodner RD, Zhou H: An FHA domain-mediated protein interaction network of Rad53 reveals its role in polarized cell growth. J Cell Biol 2006,175(5):743–753.View ArticlePubMed CentralPubMedGoogle Scholar
- Truman AW, Kim KY, Levin DE: Mechanism of Mpk1 mitogen-activated protein kinase binding to the Swi4 transcription factor and its regulation by a novel caffeine-induced phosphorylation. Mol Cell Biol 2009,29(24):6449–6461.View ArticlePubMed CentralPubMedGoogle Scholar
- Traven A, Lo TL, Pike BL, Friesen H, Guzzo J, Andrews B, Heierhorst J: Dual functions of Mdt1 in genome maintenance and cell integrity pathways in Saccharomyces cerevisiae. Yeast 27(1):41–52.Google Scholar
- Mizunuma M, Hirata D, Miyaoka R, Miyakawa T: GSK-3 kinase Mck1 and calcineurin coordinately mediate Hsl1 down-regulation by Ca2+ in budding yeast. EMBO J 2001,20(5):1074–1085.View ArticlePubMed CentralPubMedGoogle Scholar
- Mathews CK, Wheeler LJ: Measuring DNA precursor pools in mitochondria. Methods Mol Biol 2009, 554: 371–381.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.